Review



human lung microvascular ecs (hmvec-l)  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza human lung microvascular ecs (hmvec-l)
    Human Lung Microvascular Ecs (Hmvec L), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung microvascular ecs (hmvec-l)/product/Lonza
    Average 90 stars, based on 1 article reviews
    human lung microvascular ecs (hmvec-l) - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    95
    ATCC human dermal microvascular endothelial cells hmvec
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Dermal Microvascular Endothelial Cells Hmvec, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human dermal microvascular endothelial cells hmvec/product/ATCC
    Average 95 stars, based on 1 article reviews
    human dermal microvascular endothelial cells hmvec - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    90
    Lonza human lung microvascular ecs (hmvec-l)
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Lung Microvascular Ecs (Hmvec L), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung microvascular ecs (hmvec-l)/product/Lonza
    Average 90 stars, based on 1 article reviews
    human lung microvascular ecs (hmvec-l) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Lonza human lung microvascular endothelial cells (hmvecs)
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Lung Microvascular Endothelial Cells (Hmvecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung microvascular endothelial cells (hmvecs)/product/Lonza
    Average 90 stars, based on 1 article reviews
    human lung microvascular endothelial cells (hmvecs) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Lonza human lung microvascular endothelial cells hmvec-l
    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human <t>microvascular</t> <t>endothelial</t> cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
    Human Lung Microvascular Endothelial Cells Hmvec L, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung microvascular endothelial cells hmvec-l/product/Lonza
    Average 90 stars, based on 1 article reviews
    human lung microvascular endothelial cells hmvec-l - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Lonza human cardiac microvascular endothelial cells (hmvec-c)
    CHOP downregulation in human cardiac <t>microvascular</t> <t>endothelial</t> cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)
    Human Cardiac Microvascular Endothelial Cells (Hmvec C), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cardiac microvascular endothelial cells (hmvec-c)/product/Lonza
    Average 90 stars, based on 1 article reviews
    human cardiac microvascular endothelial cells (hmvec-c) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Lonza d-hmvec-blneos
    CHOP downregulation in human cardiac <t>microvascular</t> <t>endothelial</t> cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)
    D Hmvec Blneos, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d-hmvec-blneos/product/Lonza
    Average 90 stars, based on 1 article reviews
    d-hmvec-blneos - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Lonza human lung microvascular endothelial cells (hmvec-l)
    CHOP downregulation in human cardiac <t>microvascular</t> <t>endothelial</t> cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)
    Human Lung Microvascular Endothelial Cells (Hmvec L), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung microvascular endothelial cells (hmvec-l)/product/Lonza
    Average 90 stars, based on 1 article reviews
    human lung microvascular endothelial cells (hmvec-l) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Activity Assay

    (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Expressing, Control

    Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.

    Journal: Clinical Science (London, England : 1979)

    Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge

    doi: 10.1042/CS20256682

    Figure Lengend Snippet: Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.

    Article Snippet: Human dermal microvascular endothelial cells (HMVEC) were obtained from the American Type Culture Collection (ATCC CRL-4060; Manassas, VA, U.S.A.).

    Techniques: Control, CCK-8 Assay, Migration, Phospho-proteomics, Expressing

    CHOP downregulation in human cardiac microvascular endothelial cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Endothelial CHOP as a central mechanism in renovascular hypertension-induced vascular endothelial dysfunction and cardiac fibrosis

    doi: 10.1007/s00018-025-05741-6

    Figure Lengend Snippet: CHOP downregulation in human cardiac microvascular endothelial cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)

    Article Snippet: 0.3 × 10 6 Human Cardiac Microvascular Endothelial Cells (HMVEC-C, Cat No: CC-7030, from Lonza) were seeded in a six-well plate and grown in EGMTM-2MV BulletKitTM Medium complete media (Cat No: CC-3202, from Lonza) for 24 h at 37 °C, 5% CO 2 , and 95% air.

    Techniques: Western Blot, Cell Culture, Transfection, shRNA, Plasmid Preparation